Literature DB >> 19953621

Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited.

Gregory T Wolf1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 19953621     DOI： 10.1002/hed.21296

Source DB:  PubMed          Journal:  Head Neck        ISSN： 1043-3074            Impact factor:   3.147


× No keyword cloud information.
  11 in total

1.  [Recent advances in the treatment of laryngeal and hypopharyngeal carcinoma].

Authors:  H E Eckel
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

2.  Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.

Authors:  Gregory T Wolf; Emily Bellile; Avraham Eisbruch; Susan Urba; Carol R Bradford; Lisa Peterson; Mark E Prince; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Scott A McLean; Jeffery Moyer; Jeremy M G Taylor; Francis P Worden
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223

3.  Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery.

Authors:  Dimitrios Pantazis; Georgia Liapi; Dimitrios Kostarelos; Georgios Kyriazis; Theodoros-Leonidas Pantazis; Maria Riga
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-29       Impact factor: 2.503

4.  Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy.

Authors:  Thomas F Pezier; Iain J Nixon; Anil Joshi; Leo Pang; Teresa Guerrero-Urbano; Richard Oakley; Jean-Pierre Jeannon; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-09       Impact factor: 2.503

5.  Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma.

Authors:  Thomas F Pezier; Iain J Nixon; Anil Joshi; Teresa Guerrero-Urbano; Richard Oakley; Jean-Pierre Jeannon; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-23       Impact factor: 2.503

6.  Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.

Authors:  Huaising C Ko; Paul M Harari; Shuai Chen; Aaron M Wieland; Menggang Yu; Andrew M Baschnagel; Randall J Kimple; Matthew E Witek
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-11-01       Impact factor: 6.223

7.  Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  James Bonner; Jordi Giralt; Paul Harari; Sharon Spencer; Jeltje Schulten; Anwar Hossain; Shao-Chun Chang; Steve Chin; José Baselga
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-09-01       Impact factor: 6.223

8.  Stage Migration and Survival Trends in Laryngeal Cancer.

Authors:  Michael M Li; Songzhu Zhao; Antoine Eskander; Chandler Rygalski; Guy Brock; Anuraag S Parikh; Catherine T Haring; Brian Swendseid; Kevin Y Zhan; Carol R Bradford; Theodoros N Teknos; Ricardo L Carrau; Kyle K VanKoevering; Nolan B Seim; Matthew O Old; James W Rocco; Sidharth V Puram; Stephen Y Kang
Journal:  Ann Surg Oncol       Date:  2021-07-15       Impact factor: 4.339

9.  Supratracheal laryngectomy: current indications and contraindications.

Authors:  G Succo; M Bussi; L Presutti; S Cirillo; E Crosetti; A Bertolin; L Giordano; G Molteni; M Petracchini; A E Sprio; G N Berta; A Fornari; G Rizzotto
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

10.  Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions.

Authors:  James A Bonner; Drexell H Boggs
Journal:  Transl Cancer Res       Date:  2019-03       Impact factor: 1.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.